Just call it LLNS, LyonHeart no more

Share this article:
The agency formerly known as LyonHeart is going back to its maiden name ahead of the rollout of a new Omnicom healthcare agency network.

“We found that a lot of [client] companies were still calling us LLNS, including our biggest client,” said Sharon Callahan, who will serve as CEO of the new network. “It seems like a lot of the equity is in LLNS, and we don't want to confuse the marketplace with another new name,” she added.

Callahan was mum on the details of the new network but said it will be an integrated offering consisting of five agencies, with PR, CRM, managed care consulting and med ed.

LLNS rebranded under the LyonHeart name in 2007, shortly after it was folded into the TBWA\WorldHealth network. LLNS was quietly demerged from TBWA earlier this year. The shop's top clients include Pfizer, Eisai and Daiichi Sankyo.

The new network, said Callahan, will be based on the recent global integration of a big pharma client's business across Omnicom, which she presided over. The process took two years. “We found out what worked,” said Callahan. “We're trying to achieve true collaboration across disciplines.”

Callahan was EVP healthcare for Omnicom's Diversified Agency Services group before taking the CEO post. Anne Devereux, who was chairman and CEO of TBWA/WorldHealth, is chairman of the new network.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?